Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of Sunday, August 30, 2026.
OPERATING CASH FLOW YIELD
N/A
PDS Biotechnology Corporation
Market Cap
$11.79M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$438.82M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$492.43M
Operating Cash Flow Yield
6.13%
TTM Avg
6.72%
3Y Avg
6.90%
5Y Avg
5.79%
Market Cap
$1.18B
Operating Cash Flow Yield
22.32%
TTM Avg
24.29%
3Y Avg
19.89%
5Y Avg
14.71%
Market Cap
$2.23B
Operating Cash Flow Yield
14.31%
TTM Avg
10.72%
3Y Avg
10.07%
5Y Avg
8.95%
Market Cap
$3.06B
Operating Cash Flow Yield
4.05%
TTM Avg
4.66%
3Y Avg
2.91%
5Y Avg
2.91%
Market Cap
$5.00B
Operating Cash Flow Yield
6.00%
TTM Avg
5.25%
3Y Avg
3.55%
5Y Avg
2.86%
Market Cap
$5.40B
Operating Cash Flow Yield
5.22%
TTM Avg
6.02%
3Y Avg
4.28%
5Y Avg
3.94%
Market Cap
$6.43B
Operating Cash Flow Yield
3.99%
TTM Avg
4.13%
3Y Avg
3.09%
5Y Avg
2.84%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PDS Biotechnology Corporation (PDSB) | $11.79M | N/A | N/A | N/A | N/A |
| Shoulder Innovations, Inc. (SI)vs › | $438.82M | N/A | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $492.43M | 6.13% | 6.72% | 6.90% | 5.79% |
| Teladoc Health, Inc. (TDOC)vs › | $1.18B | 22.32% | 24.29% | 19.89% | 14.71% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.23B | 14.31% | 10.72% | 10.07% | 8.95% |
| TransMedics Group, Inc. (TMDX)vs › | $3.06B | 4.05% | 4.66% | 2.91% | 2.91% |
| Doximity, Inc. (DOCS)vs › | $5.00B | 6.00% | 5.25% | 3.55% | 2.86% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.40B | 5.22% | 6.02% | 4.28% | 3.94% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.43B | 3.99% | 4.13% | 3.09% | 2.84% |
| Chemed Corporation (CHE)vs › | $6.84B | 5.55% | 6.70% | 5.00% | 4.63% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
